NZ's A2 Milk Lifts Annual Earnings Forecast On Strong Infant Formula Demand, Weaker Kiwi

Reuters
Nov 20, 2025

Nov 20 (Reuters) - New Zealand's a2 Milk ATM.NZ on Thursday upgraded its full-year earnings forecast, citing stronger-than-expected trading across its core product categories and a weaker New Zealand dollar, but failed to woo investors with shares hitting a near one-month low.

The Auckland-headquartered firm said trading in infant milk formula, or IMF, its top market, was stronger than expected, with English-label IMF revenue growth forecast to outpace China-label IMF growth.

The company, which also sells fresh milk, said movements in actual and forecast currency rates, reflecting a weaker New Zealand dollar, are expected to inflate reported sales and expenses.

Shares of the company pared some of its early losses to trade 0.8% down as of 0001 GMT. The stock fell as much as 4.7%, hitting its lowest level since October 28 in early trade.

"Moving from high single-digit to low double-digit growth is not cosmetic," said Jeremy Sullivan, investment adviser at Hamilton Hindin Greene.

Tom McBride, founder and financial adviser at McBride Wealth, said the stock movement "could be a case of investors expecting higher earnings growth, or it may be a reaction to the increase in capital expenditure."

IMF is the company's top product category, primarily targeting babies and toddlers, and contributed 67% of total sales revenue in fiscal 2025, according to its annual report.

The dairy company now expects low-double-digit revenue growth from continuing operations in fiscal 2026, higher than its previous forecast of high-single-digit growth, and anticipates slightly higher net profit after tax than last year.

Earlier in August, the company announced its fiscal 2025 results and logged a group revenue from continuing operations of NZ$1.76 billion ($984.02 million), while it recorded a 21% jump in its NPAT to NZ$202.9 million.

Trading was also stronger in its other nutritionals and liquid milk product segments, a2 Milk added.

Its nutritionals portfolio comprises non-IMF powdered a2 Milk products, as well as China & other Asia liquid milk products.

The company also expanded the portfolio in the second half of 2025 with the launch of new kids fortified milk powder product, a move that has been received well by the consumers, as per a2's annual report.

($1 = 1.7886 New Zealand dollars)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10